Legend Biotech To Participate In The Morgan Stanley Global Healthcare Conference
The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of the Legend Biotech website. The webcast replay will be available approximately 48 hours after the webcast.
ABOUT LEGEND BIOTECH
With over 3,000 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. Legend Biotech is at the forefront of the CAR-T cell therapy revolution with CARVYKTI®, a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets with collaborator Johnson & Johnson. Centered in the United States, Legend Biotech is building an end-to-end cell therapy company by expanding its leadership to maximize CARVYKTI's patient access and therapeutic potential. From this platform, Legend Biotech plans to drive future innovation across its pipeline of cutting-edge cell therapy modalities.
Learn more at and follow us on X, Instagram, and LinkedIn.
INVESTOR CONTACT:
Caroline Paul
Tel: (973) 650-5832
...
PRESS CONTACT:
Kim Fox
Tel: (848) 388-8445
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment